Literature DB >> 19007820

The cognitive and histopathological effects of chronic 4-vessel occlusion in rats depend on the set of vessels occluded and the age of the animals.

Carla Aparecida Barros1, Roberta Ekuni, Marco Aurélio Moro, Francine Martins Pereira, Marli Aparecida Dos Santos Pereira, Humberto Milani.   

Abstract

Continuing previous efforts to develop the 4-vessel occlusion (4-VO) model of chronic cerebral hypoperfusion (CCH), here we evaluated whether permanent, stepwise 4-VO causes both learning deficits, hippocampal neurodegeneration and retinal lesion in young, middle-aged or aged rats. Chronic 4-VO was induced by ligation of different sets of vessels, i.e., the vertebral arteries (VA) plus common carotid arteries (CCA) (4-VO/CCA model) or the VA plus internal carotid arteries (ICA) (4-VO/ICA model) with a 1-week interstage interval. Forty days after the 4-VO, the rats were tested for spatial learning impairment, and then examined for hypoxic/ischemic damage. Young, 4-VO/CCA rats exhibited cognitive impairment, hippocampal neurodegeneration and retinal lesion (p<0.0001-0.05). After 4-VO/ICA, neither young nor middle-aged rats exhibited any learning deficits, hippocampal or retinal damage. In aged rats, chronic 4-VO/ICA caused a mild learning deficit (p<0.05). A significant effect of training was observed for the old, sham-operated rats (p<0.0001-0.001), but not for the aged 4-VO/ICA rats (p>0.05). On average, hippocampal cell density did not change after 4-VO/ICA in aged rats, but 3 of 10 subjects exhibited reduced pyramidal cell counts in all hippocampal subfields. Retinal morphology appeared to be unaffected in the 4-VO/ICA aged rats. These data suggest that the 4-VO/ICA model, but not the 4-VO/CCA model, is a suitable paradigm to study the behavioral outcome of CCH given the preservation of the retina after 4-VO/ICA. Moreover, the age at which 4-VO/ICA occurs seems to be an important factor for determining the behavioral and neuropathological changes.

Entities:  

Mesh:

Year:  2008        PMID: 19007820     DOI: 10.1016/j.bbr.2008.10.023

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

1.  The effects of two-stage carotid occlusion on spatial memory and pro-inflammatory markers in the hippocampus of rats.

Authors:  Mehrnoush Moghaddasi; Majid Taati; Payman Asadian; Ali Reza Khalatbary; Raheleh Asaei; Naser Pajouhi
Journal:  J Physiol Sci       Date:  2016-07-28       Impact factor: 2.781

2.  Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone.

Authors:  Nektaria Nicolakakis; Tahar Aboulkassim; Antonio Aliaga; Xin-Kang Tong; Pedro Rosa-Neto; Edith Hamel
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-23       Impact factor: 6.200

3.  Altered expression of neurofilament 200 and amyloid-β peptide (1-40) in a rat model of chronic cerebral hypoperfusion.

Authors:  Weihua Liang; Weiwei Zhang; Shifu Zhao; Qianning Li; Hua Liang; Rongchuan Ceng
Journal:  Neurol Sci       Date:  2014-12-02       Impact factor: 3.307

4.  Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia.

Authors:  Mariana I Holubiec; Juan I Romero; Juan Suárez; Manuel Portavella; Emilio Fernández-Espejo; Eduardo Blanco; Pablo Galeano; Fernando Rodríguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  2018-07-29       Impact factor: 4.530

Review 5.  Neurovascular function in Alzheimer's disease patients and experimental models.

Authors:  Nektaria Nicolakakis; Edith Hamel
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-06       Impact factor: 6.200

6.  Collapsin Response Mediator Protein-2-induced Retinal Ischemic Injury in a Novel Mice Model of Ocular Ischemia Syndrome.

Authors:  Yu Wang; Xiao-Lei Wang; Guo-Li Xie; Hong-Yang Li; Yan-Ling Wang
Journal:  Chin Med J (Engl)       Date:  2017-06-05       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.